China Antiretroviral Treatment Adherence for Life (AFL)
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring HIV antiretroviral treatment adherence intervention China, adherence to antiretroviral treatment, treatment experienced
Eligibility Criteria
Inclusion Criteria:
- Patients who are 18 years of age or older, currently on antiretroviral treatment or about to begin it, live in the study catchment area, and are willing to provide informed consent.
Exclusion Criteria:
- Persons below the age of 18 years, persons who are not currently on or about to start antiretroviral treatment, persons who live outside the study catchment area, or person not willing to provide informed consent.
Sites / Locations
- Dali Second People's Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention
Comparison
The intervention group patients were given their electronic drug monitoring feedback data at each monthly visit. The study coordinator would quickly calculate whether the patient's adherence was below 95% in the previous month. If so, that patient was flagged for enhanced counseling with a clinic doctor and this counseling was based on a printout containing the electronic drug monitoring data.
The comparison group patients were not given the data from the electronic data monitoring feedback data. Instead, they filled out a self report form that all patients fill out. If they indicated in this report that their adherence in the previous was less than 95%, then they were flagged for "enhanced counseling" with a doctor. This counseling was based on the patient's self report. Thus both groups received enhanced counseling if they indicated poor adherence, but only the intervention group were given their electronic data output.